Zemer Gitai likes to say of his thus far short, but fruitful, science career that he is devolving. Since he studied cancer in mice as an undergraduate student at Massachusetts Institute of Technology, he has been transitioning his work to increasingly simpler biologic systems. For now, he has settled on bacteria.












